Add to ORKGIn this chapter we describe and discuss the International AIDS Vaccine Initiative (IAVI) as a case study for understanding the emerging role of health product development partnerships (PDPs) in providing new solutions to health problems in low-resource settings. Based on a broader analysis of the emergence and impact of global health partnerships, this chapter highlights the need for multidisciplinary and multi-institutional approaches, which are exemplified by IAVI and similar PDPs, and considers the extent to which these translational approaches are leading the way in terms of developing new vaccines for HIV/AIDS and other neglected diseases. The contextual historical, organisational, and scientific issues surrounding these efforts are...
Vaccine production is now at the heart of the debate on development. This paper argues that, as well...
Vaccine production is now at the heart of the debate on development. This paper argues that, as well...
Recently, Product Development Partnerships (PDPs) for the development of vaccines affecting primaril...
Product based public-private partnerships (PPPs), of which the International Aids Vaccine Initiative...
Presented at the GLOBELICS 6th International Conference 2008 22-24 September, Mexico City, Mexico.In...
New developments in biotechnology and the need to overcome the lack of incentive for investment in v...
The International AIDS Vaccine Initiative (IAVI) is one of a number of Product Development Partnersh...
Product based public-private partnerships (PPPs), of which the International Aids Vaccine Initiative...
Vaccine production is now at the heart of the debate on development. This paper argues that, as well...
Vaccine production is now at the heart of the debate on development. This paper argues that, as well...
In developing countries international product development partnerships engage in health product inno...
Vaccine production is now at the heart of the debate on development. This paper argues that, as well...
Vaccine production is now at the heart of the debate on development. This paper argues that, as well...
Vaccine production is now at the heart of the debate on development. This paper argues that, as well...
New developments in biotechnology and the need to overcome the lack of incentive for investment in v...
Vaccine production is now at the heart of the debate on development. This paper argues that, as well...
Vaccine production is now at the heart of the debate on development. This paper argues that, as well...
Recently, Product Development Partnerships (PDPs) for the development of vaccines affecting primaril...
Product based public-private partnerships (PPPs), of which the International Aids Vaccine Initiative...
Presented at the GLOBELICS 6th International Conference 2008 22-24 September, Mexico City, Mexico.In...
New developments in biotechnology and the need to overcome the lack of incentive for investment in v...
The International AIDS Vaccine Initiative (IAVI) is one of a number of Product Development Partnersh...
Product based public-private partnerships (PPPs), of which the International Aids Vaccine Initiative...
Vaccine production is now at the heart of the debate on development. This paper argues that, as well...
Vaccine production is now at the heart of the debate on development. This paper argues that, as well...
In developing countries international product development partnerships engage in health product inno...
Vaccine production is now at the heart of the debate on development. This paper argues that, as well...
Vaccine production is now at the heart of the debate on development. This paper argues that, as well...
Vaccine production is now at the heart of the debate on development. This paper argues that, as well...
New developments in biotechnology and the need to overcome the lack of incentive for investment in v...
Vaccine production is now at the heart of the debate on development. This paper argues that, as well...
Vaccine production is now at the heart of the debate on development. This paper argues that, as well...
Recently, Product Development Partnerships (PDPs) for the development of vaccines affecting primaril...